Emergent Biosolutions EBS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's operating income?
- Emergent Biosolutions (EBS) reported operating income of $10.5M in Q1 2026.
- How has Emergent Biosolutions's operating income changed year-over-year?
- Emergent Biosolutions's operating income decreased by 79.0% year-over-year, from $49.9M to $10.5M.
- What is the long-term trend for Emergent Biosolutions's operating income?
- Over 3 years (2021 to 2024), Emergent Biosolutions's operating income has grown at a -31.7% compound annual growth rate (CAGR), from $341.4M to -$108.7M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.